Prescribing menopausal hormone therapy: an evidence-based approach

R Sood, SS Faubion, CL Kuhle, JM Thielen… - … journal of women's …, 2014 - Taylor & Francis
The constantly changing landscape regarding menopausal hormone therapy (MHT) has
been challenging for providers caring for menopausal women. After a decade of fear and …

Treatment of menopausal symptoms: what shall we do now?

M Hickey, SR Davis, DW Sturdee - The Lancet, 2005 - thelancet.com
During the past few years, many women and doctors have revised their opinions of hormone
replacement therapy (HRT) for menopausal symptoms, and a substantial number of …

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Increased incidence of endometrial cancer following the women's health initiative: an assessment of risk factors

GD Constantine, G Kessler, S Graham… - Journal of women's …, 2019 - liebertpub.com
Abstract Background: The Surveillance, Epidemiology, and End Result (SEER) database
shows a variable increase in endometrial cancer incidence over time. The objective of this …

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

TJ De Villiers, A Pines, N Panay, M Gambacciani… - …, 2013 - Taylor & Francis
Ten years after the first results from the Women's Health Initiative (WHI) trial were published,
it seems that the atmosphere around the issue of menopausal hormone therapy (MHT) is …

The 2017 hormone therapy position statement of the North American Menopause Society

North American Menopause Society - Menopause, 2017 - journals.lww.com
Abstract The 2017 Hormone Therapy Position Statement of The North American Menopause
Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North …

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health

DW Sturdee, A Pines… - …, 2011 - Taylor & Francis
The past decade has seen marked fluctuations in opinions concerning the merits and risks
of postmenopausal hormone replacement therapy (HRT). In July 2002, menopause …

Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration

ML Stefanick - The American journal of medicine, 2005 - Elsevier
The US Food and Drug Administration (FDA) approved marketing of diethylstilbestrol in
1941 and conjugated equine estrogens (CEE) in 1942 for treatment of menopausal …

[HTML][HTML] American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause

NF Goodman, RH Cobin, SB Ginzburg… - Endocrine …, 2011 - endocrinepractice.org
AACE= American Association of Clinical Endocrinologists; BEL= best evidence level; CAD=
coronary artery disease; CCS= consecutive case series; CEE= conjugated equine estrogen; …

Bioidentical hormone therapy

JA Files, MG Ko, S Pruthi - Mayo Clinic Proceedings, 2011 - Elsevier
The change in hormonal milieu associated with perimenopause and menopause can lead to
a variety of symptoms that can affect a woman's quality of life. Postmenopausal hormone …